Stay updated on SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma

Sign up to get notified when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.
Latest website image capture
Clouds background image

Latest updates to the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The Locations section was updated to reflect study sites by state, and the page revision was bumped to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T10:15:15.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Site revision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:53:15.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    - Revision: v3.3.1 was added. - Revision: v3.2.0 was removed.
    Difference
    0.0%
    Check dated 2025-11-24T14:31:21.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The government funding status banner was removed. All study details, eligibility criteria, locations, and outcomes remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-17T06:38:27.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    Non-significant changes include metadata updates (e.g., last update date, results submission dates) with no changes to core study details, eligibility criteria, arms, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:12:06.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    2%
    Check dated 2025-10-05T09:53:27.000Z thumbnail image

Stay in the know with updates to SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma

Enter your email address, and we'll notify you when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.